Condition: Alzheimer Dementia · Agitation,Psychomotor · Sponsor: Brent Forester
This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will also determine the tolerability/safety outcomes of ECT+UC.
This description comes directly from the study's public registry record.
Jefferson Mattingly, BA · 617-855-3168 · jmattingly@mclean.harvard.edu
Sarah Howie, BS · 617-855-3168 · showie1@mgb.org
Always discuss trial participation with your own doctor first.
| Emory Healthcare | Atlanta, Georgia, United States | Recruiting |
| McLean Hospital | Belmont, Massachusetts, United States | Recruiting |
| Pine Rest Christian Mental Health Services | Grand Rapids, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Northwell Health | Glen Oaks, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03926520